PSTI Related Analyst Comments

Jun 20, 2011 07:35 AM Needham & Company Maintains a 'Buy' on Pluristem Therapeutics (PSTI); Enters into Early-Stage Licensing Agreement Around PLX Cells

May 17, 2011 07:42 AM Needham & Company Reiterates a 'Buy' on Pluristem Therapeutics (PSTI); Comprehensive Program in PAD Planned, Solid Cash Position to Support Operations

Aug 23, 2005 09:56 AM JMP Securities Initiates Coverage on a Number of Healtchcare Software Stocks